Axiom Investors LLC Halozyme Therapeutics, Inc. Transaction History

Axiom Investors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $169,903 - $205,179	4,660 Added 17.22%	31,715 $1.21 Million
Q2 2023 Aug 10, 2023	SELL	$30.28 - $38.74 $414,987 - $530,931	-13,705 Reduced 33.62%	27,055 $975,000
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $2.35 Million - $3.99 Million	-71,605 Reduced 63.73%	40,760 $1.56 Million
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $42,463 - $63,006	-1,060 Reduced 0.93%	112,365 $6.39 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $1.02 Million - $1.37 Million	26,500 Added 30.49%	113,425 $4.49 Million
Q2 2022 Aug 11, 2022	BUY	$37.35 - $48.3 $836,378 - $1.08 Million	22,393 Added 34.7%	86,925 $3.83 Million
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $572,710 - $735,548	-17,914 Reduced 21.73%	64,532 $2.57 Million
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $443,857 - $568,421	-13,949 Reduced 14.47%	82,446 $3.32 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $424,708 - $512,476	-11,040 Reduced 10.28%	96,395 $3.92 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $178,858 - $236,282	4,605 Added 4.48%	107,435 $4.88 Million
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $1.1 Million - $1.44 Million	-27,920 Reduced 21.35%	102,830 $4.29 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $3.37 Million - $5.7 Million	130,750 New	130,750 $5.58 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.